BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticalsBusiness Overview: BDHIL is a full-service Contract Manufacturing Organization for production of Pharmaceutical, Oncological Products and associated packaging services. It is an exporter and manufacturer of therapeutic formulations covering a wide range of pharmaceuticals
BDH Industries has disclosed its financial results for the quarter ended June 30, 2025. The company reported a total income from operations of ₹19.17 Cr, up from ₹16.63 Cr in the prior-year quarter. Net profit after tax rose to ₹1.83 Cr from ₹1.57 Cr, leading to an improved Earnings Per...
BDH Industries conducted its 35th Annual General Meeting via Video Conferencing, presided over by Ms. Jayashree Nair and attended by key management and auditors. Shareholders approved the Audited Financial Statements for the year ended March 31, 2025, and sanctioned the declaration of a dividend on Equity Shares. Important resolutions passed...
BDH Industries has informed shareholders about the upcoming transfer of unclaimed dividends and associated shares to the Investor Education and Protection Fund (IEPF). This applies to dividends unpaid or unclaimed for seven consecutive years or more. Shareholders are urged to claim their dividends by October 20, 2025. Failure to do...
BDH Industries has informed shareholders without registered email addresses about how to access the Notice for the 35th Annual General Meeting (AGM) and the Annual Report for FY 2024-25. The company sent physical letters containing web-links and QR codes for digital access. The 35th AGM is scheduled for August 8,...
BDH Industries has announced a certificate from its Registrar and Share Transfer Agent confirming that all securities received for dematerialisation during the quarter were processed—accepted or rejected—and the corresponding certificates were cancelled after verification. The securities are listed on the relevant stock exchanges, and the depositories have been updated as...
